SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Act of 1934
Date of Report (Date of earliest event reported): July 17, 2001
BERGEN BRUNSWIG CORPORATION
(Exact name of Registrant as specified in its charter)
New Jersey 1-5110 22-1444512
---------- ------ ----------
(State or other (Commission (I.R.S. Employer
jurisdiction of File Number) Identification No.)
incorporation)
4000 Metropolitan Drive
Orange, California 92868-3510
(Address of principal executive offices, including zip code)
(714) 385-4000
(Registrant's telephone number, including area code)
Item 5. Other Events
On July 17, 2001, Bergen Brunswig issued a press release relating to the
initiation of a cash tender offer by its wholly owned subsidiary, PharMerica,
Inc. ("PharMerica"), to purchase all of PharMerica's outstanding 8.375% Senior
Subordinated Notes due in 2008 (the "Notes") and consent solicitation. The
consent solicitation seeks consents from holders of the Notes to eliminate
substantially all of the restrictive covenants contained in the Notes' governing
indenture. A copy of the press release is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.
Item 7. Financial Statements and Exhibits
(c) Exhibits
99.1 Press release issued by Bergen Brunswig
Corporation on July 17, 2001.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Bergen
Brunswig Corporation has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
BERGEN BRUNSWIG CORPORATION
Date: July 18, 2001 By: /S/ Milan A. Sawdei
------------------------
Name: Milan A. Sawdei
Title: Senior Executive Vice President,
Chief Legal and Compliance
Officer, and Secretary
EXHIBIT INDEX
Exhibit
No. Description
- -------- --------------
99.1 Press release issued by Bergen Brunswig Corporation on July 17, 2001.